T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.94B |
| 2 |
Broadcom
AVGO
|
+$2.74B |
| 3 |
Microsoft
MSFT
|
+$2.33B |
| 4 |
Advanced Micro Devices
AMD
|
+$1.47B |
| 5 |
GE Aerospace
GE
|
+$1.27B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$3.42B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$2.44B |
| 3 |
Apple
AAPL
|
+$2.42B |
| 4 |
FISV
Fiserv Inc
FISV
|
+$2.3B |
| 5 |
Eli Lilly
LLY
|
+$1.78B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.73% |
| 2 | Financials | 12.11% |
| 3 | Healthcare | 10.97% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Communication Services | 10.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1276
Varonis Systems
VRNS
$4.82B
| $4.71M | ﹤0.01% |
92,786
+8,529
| +10% | +$388K |
|
1277
First Industrial Realty Trust
FR
$8.4B
| $4.71M | ﹤0.01% |
97,808
-1,440
| -1% | -$70.2K |
|
1278
Alaska Air
ALK
$5.3B
| $4.7M | ﹤0.01% |
95,046
+2,508
| +3% | +$122K |
|
|
ZBIO
1279
Zenas BioPharma
ZBIO
$1.98B
| $4.7M | ﹤0.01% |
485,202
-32,404
| -6% | -$316K |
|
1280
CareTrust REIT
CTRE
$9.18B
| $4.68M | ﹤0.01% |
153,016
+17,139
| +13% | +$494K |
|
1281
Jazz Pharmaceuticals
JAZZ
$16B
| $4.68M | ﹤0.01% |
44,064
+1,625
| +4% | +$177K |
|
1282
Darling Ingredients
DAR
$10B
| $4.66M | ﹤0.01% |
122,691
+2,541
| +2% | +$83.6K |
|
1283
Dolby
DLB
$5.84B
| $4.65M | ﹤0.01% |
62,635
+649
| +1% | +$48.6K |
|
|
BBNX
1284
Beta Bionics
BBNX
$780M
| $4.63M | ﹤0.01% |
317,943
-318,261
| -50% | -$4.51M |
|
|
HEPS
1285
D-Market Electronic Services & Trading
HEPS
$1.01B
| $4.62M | ﹤0.01% |
1,710,733
-124,300
| -7% | -$338K |
|
|
ORKA
1286
Oruka Therapeutics
ORKA
$7.11B
| $4.61M | ﹤0.01% |
410,881
-721
| -0.2% | -$7.51K |
|
1287
STAG Industrial
STAG
$7.12B
| $4.6M | ﹤0.01% |
126,689
+4,868
| +4% | +$168K |
|
1288
Upstart Holdings
UPST
$2.83B
| $4.56M | ﹤0.01% |
70,512
+9,984
| +16% | +$490K |
|
1289
Allogene Therapeutics
ALLO
$683M
| $4.56M | ﹤0.01% |
4,030,872
-175,132
| -4% | -$233K |
|
1290
Shake Shack
SHAK
$2.94B
| $4.55M | ﹤0.01% |
32,374
+3,549
| +12% | +$387K |
|
1291
Ryder
R
$10.1B
| $4.55M | ﹤0.01% |
28,613
+437
| +2% | +$64.2K |
|
1292
WEX
WEX
$6.48B
| $4.54M | ﹤0.01% |
30,895
-1,793
| -5% | -$241K |
|
|
AL
1293
DELISTED
Air Lease Corp
AL
| $4.52M | ﹤0.01% |
77,222
-834
| -1% | -$43.4K |
|
1294
MGIC Investment
MTG
$6.29B
| $4.52M | ﹤0.01% |
162,182
+3,971
| +3% | +$102K |
|
1295
Zurn Elkay Water Solutions
ZWS
$8.46B
| $4.52M | ﹤0.01% |
123,473
+11,601
| +10% | +$399K |
|
1296
LCI Industries
LCII
$2.6B
| $4.5M | ﹤0.01% |
49,377
+1,445
| +3% | +$123K |
|
1297
Graphic Packaging
GPK
$3.46B
| $4.5M | ﹤0.01% |
213,273
+5,989
| +3% | +$138K |
|
1298
Amalgamated Financial
AMAL
$1.52B
| $4.45M | ﹤0.01% |
142,694
+10,526
| +8% | +$308K |
|
1299
iShares Russell Mid-Cap Growth ETF
IWP
$21.1B
| $4.45M | ﹤0.01% |
32,086
| – | – |
|
1300
Archer Aviation
ACHR
$5.37B
| $4.44M | ﹤0.01% |
408,954
+142,772
| +54% | +$1.34M |
|
Similar funds
T. Rowe Price Associates's Q2 2025 Portfolio in Review
As of Q2 2025, T. Rowe Price Associates held 3,193 positions worth $883B, up 8.8% from $812B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
T. Rowe Price Associates's Q2 2025 filing shows 153 new, 2,010 increased, 803 reduced and 136 closed positions. Its largest new stake was Ralliant Corp: 4,667,638 shares worth $226M. The largest sale was Amazon, an estimated $3.42B.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 30% a quarter earlier, followed by Financials and Healthcare.
- T. Rowe Price Associates's largest Q2 2025 buy was Ralliant Corp: 4,667,638 shares worth $226M.
- T. Rowe Price Associates added most to NVIDIA in Q2 2025, an estimated $3.94B increase.
- T. Rowe Price Associates's biggest Q2 2025 reduction was Amazon, cutting an estimated $3.42B.
- T. Rowe Price Associates fully exited US Steel in Q2 2025, selling an estimated $146M.
- T. Rowe Price Associates's ten largest holdings make up 36% of its $883B portfolio in Q2 2025.
- T. Rowe Price Associates opened 153 new positions and closed 136 in Q2 2025.
- T. Rowe Price Associates's portfolio value rose 8.8% quarter-over-quarter to $883B.
Based on T. Rowe Price Associates's 13F filing for Q2 2025, filed 14 Aug 2025.